A potent SARS-CoV-2 neutralising nanobody shows therapeutic efficacy in the Syrian golden hamster model of COVID-19
Jiandong Huo(Guangzhou Experimental Station), Raymond J. Owens(University of Oxford)
Cited by 154
Related Papers
SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses
|Cell|2022|1k
A versatile ligation-independent cloning method suitable for high-throughput expression screening applications
|Nucleic Acids Research|2007|571
Site-specific attachment to recombinant antibodies via introduced surface cysteine residues
|Protein Engineering Design and Selection|1990|66
Isotype choice for chimeric antibodies affects binding properties.
|Journal of Biological Chemistry|1994|51